Go to Top

June 2017

Repligen to buy filtration company Spectrum for $359 million in cash and stock

Waltham life sciences company Repligen Corp., which sells products that help biotechs clear and purify drugs, Friday said it has agreed to pay $359 million to acquire privately held filtration company Spectrum Laboratories Inc. The proposed deal, which includes a cash payment of $120 million along with 6.1 million shares of Repligen stock, will strengthen Repligen’s position in bioprocess filtration, a key component of the fast-growing biomanufacturing sector. Spectrum, based …Read More